Canagliflozin as a Potential Preclinical Therapy for Tuberous Sclerosis Complex: Inhibition of Tsc2 (-/-) Cell Proliferation via Cell Cycle Arrest and Mitochondrial Dysfunction.
卡格列净作为结节性硬化症的潜在临床前疗法：通过细胞周期阻滞和线粒体功能障碍抑制 Tsc2 (-/-) 细胞增殖。
期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S525749
Ye Juan, Liu Boyuan, Wu Jing, Gao Hongliang, Wei Qingyun, Su Kelei, Zheng Kai, Dai Xuening, Xu Tao, Wang Yuqi, Liu Shuangchi, Peng Xing, Gou Liming, Zhao Yinjuan, Xue Bin
